Market: |
NYSE Euronext à Paris (compartiment B) | |
Type: |
Continuous | |
Index: |
CAC Small, Gaïa Index. Naturex is eligible for the "long-only" DSS | |
ISIN: |
FR0000054694 (ordinary shares) et FR0010833251 (preferred shares) | |
Mnemo: |
NRX | |
Bloomberg: |
NTRX:FP | |
Reuters: |
NATU.PA | |
DR Symbol: |
NTUXY NATUREX has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trades on over-the-counter market in the United States. Depositary bank: BNY Mellon |
|
ICB sectorial classification: |
Food producers | |
Naturex' ownership: |
- J. Dikansky/SGD: - Natraceutical S.A: - Auto-Détention: - Public: |
21.00% of capital / 24.80% of voting rights 20.70% of capital / 3.18% of voting rights 0.06% of capital 58.24% of capital / 72.01% of voting rights |
| End of the Shareholders Agreement and the concert between J. Dikansky/SGD and Natraceutical | ||
Total outstanding shares: |
7,705,580, o/w 6,318,272 ordinary shares (ISIN FR0000054694) and 1,387,308 preferred shares (ISIN FR0010833251). | |
Share price: |
Click here | |